Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018 Document date: 2018_10_25
ID: 60ceejq1_291
Snippet: We hypothesized that Tresiba® would have longer duration of action compared to Toujeo® in healthy cats. Six healthy purpose-bred cats, each received 0.4 U/kg SQ injections of Tresiba® and Toujeo® on two different days, > 1 week apart. Blood glucose (BG) was measured every 5 min and glucose was administered intravenously at a variable rate with the goal of maintaining BG = 85 mg/dL ("isoglycemic clamp"). Glucose infusion rate was used as a mea.....
Document: We hypothesized that Tresiba® would have longer duration of action compared to Toujeo® in healthy cats. Six healthy purpose-bred cats, each received 0.4 U/kg SQ injections of Tresiba® and Toujeo® on two different days, > 1 week apart. Blood glucose (BG) was measured every 5 min and glucose was administered intravenously at a variable rate with the goal of maintaining BG = 85 mg/dL ("isoglycemic clamp"). Glucose infusion rate was used as a measure of exogenous insulin action. The Shapiro-Wilk test was used to assess normality and normally distributed parameters were compared using paired t-tests.
Search related documents:
Co phrase search for related documents- infusion rate and variable rate: 1, 2, 3, 4
- insulin action and long duration: 1
- insulin action and variable rate: 1
- normality assess and Shapiro Wilk test: 1, 2, 3
- normality assess and Shapiro Wilk test normality assess: 1, 2
Co phrase search for related documents, hyperlinks ordered by date